Particle leakage in extracorporeal blood purification systems based on microparticle suspensions

被引:6
作者
Hartmann, J
Schildboeck, C
Brandl, M
Falkenhagen, D
机构
[1] Danube Univ Krems, Ctr Biomed Technol, AT-3500 Krems, Austria
[2] Christian Dippler Lab Specif Adsorpt Technol Med, Krems, Austria
关键词
extracorporeal blood purification; particle infusion; microparticle suspension; multiple organ failure;
D O I
10.1159/000086013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The newly developed 'Microspheres based Detoxification System' (MDS) designed for any extracorporeal adsorption therapy uses microparticles as adsorbents characterized by a size of 1-20 mu m in diameter which are recirculated in the secondary (filtrate) circuit connected to a hollow fiber filter located in the primary (blood) circuit. In the case of a leakage or rupture in the hollow fiber filter, microspheres can enter patients' blood circuits and cause embolic episodes in different organs with varying degrees of clinical relevance. Aim of this study was to determine the amount of particles infused to a patient during a long-term treatment under different failure conditions of the filter. Methods: The filters were prepared by cutting single hollow fibers. Fresh-frozen plasma (FFP) and a mixture of glycerol and water were used as a medium together with microparticles potentially used in the MDS. The amounts of particles transferred from the filtrate into the primary circuit were measured. Results: The analysis of particle transfer in the case of a single cut hollow fiber inside the membrane results in particle volumes of up to 26 ml calculated for 10 h. Conclusion: Particle leakage in microparticle suspension based detoxification systems can lead to considerable particle transfer to the patient. Therefore, a particle detection unit which is able to detect critical amounts of particles (<1 ml particle volume/treatment) in the extracorporeal blood line is necessary for patient safety. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:282 / 286
页数:5
相关论文
共 17 条
[1]  
Ash S R, 2000, Ther Apher, V4, P218, DOI 10.1046/j.1526-0968.2000.00192.x
[2]   Treatment of systemic inflammatory response syndrome by push-pull powdered sorbent pheresis: A phase 1 clinical trial [J].
Ash, SR ;
Steczko, J ;
Levy, H ;
Blake, DE ;
Carr, DJ .
THERAPEUTIC APHERESIS, 2001, 5 (06) :497-505
[3]  
BRANDL M, Patent No. 4312004
[4]   Patient safety technology extracorporeal for microadsorbent systems in blood purification [J].
Falkenhagen, D ;
Strobl, W ;
Hartmann, T ;
Schrefl, A ;
Linsberger, I ;
Kellner, KH ;
Aussenegg, Z ;
Leitner, A .
ARTIFICIAL ORGANS, 2002, 26 (02) :84-90
[5]   Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances [J].
Falkenhagen, D ;
Strobl, W ;
Vogt, G ;
Schrefl, A ;
Linsberger, I ;
Gerner, FJ ;
Schoenhofen, M .
ARTIFICIAL ORGANS, 1999, 23 (01) :81-86
[6]  
FALKENHAGEN D, 1908, ASAIO J, V46, P214
[7]  
Hartmann J., 2000, International Journal of Artificial Organs, V23, P555
[8]   Prometheus® -: a new extracorporeal system for the treatment of liver failure [J].
Rifai, K ;
Ernst, T ;
Kretschmer, U ;
Bahr, MJ ;
Schneider, A ;
Hafer, C ;
Haller, H ;
Manns, MP ;
Fliser, D .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :984-990
[9]   BLOOD CLEARANCE AND ORGAN DISTRIBUTION OF INTRAVENOUSLY ADMINISTERED POLYMETHACRYLIC NANOPARTICLES IN MICE [J].
ROLLAND, A ;
COLLET, B ;
LEVERGE, R ;
TOUJAS, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (06) :481-484
[10]   CIRCULATION TIME AND BODY DISTRIBUTION OF C-14-LABELED AMINO-MODIFIED POLYSTYRENE NANOPARTICLES IN MICE [J].
SIMON, BH ;
ANDO, HY ;
GUPTA, PK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) :1249-1253